---
name: "Theranos"
slug: "theranos"
tagline: "One drop of blood. A billion lies."
founded: 2003
died: 2018
funding: "$700M+"
fundingBillions: 0.7
sector: "Health Tech"
causeOfDeath: "Fraud"
tombstoneShape: "angel"
zone: "classic"
epitaph: "If the demo always happens behind closed doors, there is no demo."
causeShort: "Blood testing technology was completely fabricated"
---

## The Story

Elizabeth Holmes was 19 years old, a sophomore at Stanford, when she walked into her professor's office and announced she was dropping out to start a blood-testing company. She would use her tuition money as seed capital. Her vision: a device that could run hundreds of diagnostic tests -- diabetes, cancer, cholesterol, everything -- from just a single drop of blood drawn by a painless finger prick. No more needles. No more vials. No more waiting.

It was a beautiful idea. There was just one problem, and it was a big one: the laws of chemistry and physics didn't cooperate. When Holmes pitched the concept to Stanford medicine professor Phyllis Gardner, she was told flatly that the idea wouldn't work. The volume of blood required for accurate diagnostic testing simply couldn't be miniaturized that far. Several other experts told her the same thing.

Holmes didn't listen. And for the next decade, that stubbornness -- rebranded as "visionary determination" -- made her one of the most celebrated founders in Silicon Valley history.

By 2014, Theranos had raised over $700 million from investors including Larry Ellison, the Walton family, Rupert Murdoch, and Betsy DeVos. The company was valued at $9 billion, making Holmes -- with her majority stake -- worth an estimated $4.5 billion. Forbes named her the youngest self-made female billionaire in America. She graced magazine covers dressed in a black turtleneck, an unmistakable homage to her idol, Steve Jobs. She even cultivated a deeper voice to project authority.

The board of directors read like a who's who of American power: Henry Kissinger, George Shultz, James Mattis, Sam Nunn. Notably absent from this roster of foreign policy luminaries? Anyone with medical or scientific expertise.

## What Went Wrong

The technology never worked. Theranos's proprietary device -- the "Edison" -- could reliably perform only about 12 of the 200+ tests the company advertised. For the rest, Theranos was secretly running samples on conventional machines made by Siemens and other manufacturers, often after diluting the tiny blood samples to volumes those machines could process. The results were unreliable. Patients received false positives and false negatives for conditions including cancer, diabetes, and HIV.

This wasn't a startup pivoting through technical challenges. This was a company that knew its product didn't work and sold it to real patients anyway. Theranos opened testing centers inside 40 Walgreens locations. Real people made real medical decisions based on results that were, in some cases, dangerously wrong.

The house of cards began collapsing in October 2015, when Wall Street Journal reporter John Carreyrou published a devastating investigation based on tips from whistleblowers -- including Tyler Shultz, the grandson of Theranos board member George Shultz. The younger Shultz had worked at Theranos, seen the problems firsthand, and tried to raise concerns internally. He was met with legal threats and intimidation from Theranos president Sunny Balwani, Holmes's secret romantic partner who ran the company day-to-day with what employees described as a culture of secrecy and fear.

The unraveling was swift. The FDA and CMS investigated. Walgreens sued. Investors sued. In 2018, Holmes and Balwani were indicted on federal fraud charges. Holmes was convicted in January 2022 on four counts of defrauding investors and sentenced to 11 years and 3 months in prison. She began serving her sentence in May 2023 at a federal prison camp in Bryan, Texas. Balwani was convicted on all 12 counts and received nearly 13 years.

Forbes revised Holmes's net worth from $4.5 billion to zero.

## The Lesson

Theranos is the definitive case study in the danger of Silicon Valley's "fake it till you make it" culture colliding with an industry where faking it can kill people. In software, you can ship a buggy product and patch it later. In medicine, a false test result can lead someone to skip treatment for cancer they actually have -- or undergo treatment for cancer they don't.

The deeper lesson is about the spectacular failure of due diligence. Investors handed over $700 million to a company whose technology had never been independently validated, whose board had zero medical expertise, and whose founder had no scientific credentials beyond two semesters of chemical engineering. They invested in a story -- a compelling young woman who channeled Steve Jobs -- instead of interrogating the science. Holmes controlled the narrative so tightly that investors weren't even allowed to stay in the room when the Edison device was supposedly running their blood. If the demo always happens behind closed doors, there is no demo.
